Contributors 13135

3 Min Read


In this issue, MX showcases the technologies and company leaders who are driving excellence in the medical device industry. In MX's annual report on the Medical Design Excellence Awards (MDEA) competition, nearly three dozen winning products—as well as the companies and suppliers behind them—are highlighted for their contributions to industry innovation. Also in this issue, MX profiles medical device executives who have risen above current market challenges—both financial and regulatory—to drive company growth and lay groundwork for future success.



Market Analysis

In "China's New Market for Medical Devices", Jean Zelt and Matthew Jordan evaluate the current economic and cultural climate surrounding the administration of healthcare in China and its market for medical devices. Zelt is a principal re­searcher for Insight Product Development (Chicago). She lives in Shanghai and manages client projects and cultural studies at the Insight Asia office. She has also lived in South Korea and has significant research experience in Asia. She can be reached at +86 021 61418476 or via e-mail at [email protected]. Matthew Jordan is director of research and interface at Insight. He has more than 12 years of experience researching users, products, environments, and work flows, as well as designing interfaces and online help systems for the software, medical, and training industries. He can be reached at 773/907-9500 or via e-mail at [email protected]. Zelt and Jordan would like to acknowledge Jiyi Liu and Zhihui Shi, researchers in Insight's Shanghai office, who assisted with the research, translation, and graphics for the article.

Business Planning & Technology Development


It's only a matter of time until FDA makes good on its promise to make electronic medical device reporting (eMDR) a mandatory requirement for medical device manufacturers. In "Electronic Medical Device Reporting", Peter Hyman points out that planning an e-reporting strategy now is essential to avoid a compliance crunch later. Hyman is a product manager at Sparta Systems (Holmdel, NJ). His diverse functions at the company include strategic consulting, business process analysis, implementation consulting, database implementation and configuration, and strategic product market analysis. Prior to joining Sparta Systems, Hyman spent more than two decades as the founder and owner of an IT consulting firm that provided sales, research, and analytical solutions to major corporations in diverse industries. He can be reached at 732/203-0400 or via e-mail at [email protected].





With so many medtech companies joining forces through mergers and acquisitions (M&A), deciding whether—and how—to enter into such agreements has become an essential part of strategic planning for any medical device manufacturer. In "Medtech M&A Trends", industry experts weigh in on the latest strategies and patterns in medtech M&A. Panelist Richard S. Cohen is president of the Walden Group Inc. (Tarrytown, NY), a strategic investment-banking firm specializing in the healthcare industry. He can be reached at 914/332-9700 or via e-mail at [email protected]. Panelist Ben Dunn is managing director of specialty investment banking firm Covington Associates (Boston). He can be reached at 617/314-3950 or via e-mail at [email protected]. Panelist Joseph E. Gilligan is a partner at the law firm Hogan & Hartson (Washington, DC). He can be reached at 202/637-5945 or via e-mail at [email protected]. Panelist J. Casey McGlynn is a partner at Wilson Sonsini Goodrich & Rosati (Palo Alto, CA), chairman of the firm's life sciences group, and a member of the firm's policy committee. He can be reached at 650/493-9300 or via e-mail at [email protected].

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like